Share this article
Share this article
ResearchAndMarkets.com s offering.
This report titled needle free diabetes management market studies various device types such as treatment devices, diagnostic devices and artificial pancreas that respectively sub-segmented. According to the International Diabetes Federation, in 2015 one in 11 adult has diabetes and by 2040 it is expected that one in 10 adults will have diabetes. The data suggests that in 2015 every 6 seconds one person dies from diabetes. Thus, diabetes management is one of the most crucial parts to prevent life threatening effects of this disease. The ongoing research and development activities in field of diagnosis and treatment of diabetes are expected to change the aspect of market in coming years.
Published: Mar 15, 2021
The global needle free drug delivery device market is likely to witness significant growth during the course of forecast period from 2018 to 2026. Transparency Market Research (TMR) found that the global needle free drug delivery devices demonstrates fragmented structure, thanks to presence of regional and international players operating in this market. The manufacturers are largely focused toward research and development activities to launch new product and improve the existing one in order to uphold growth in the needle free drug delivery device industry. Also, various manufacturers are majorly investing in the needle free drug delivery devices to attain more market share. The launch of new technology likely to intensify competition among the key players. TMR also observed that some of the companies such as Zogenix Inc., Pharmajet Inc., Antares Pharma Inc., Glide Pharmaceutical Technologies Ltd., and Injex Pharma AG are majorly investing in North A
Acromegaly Market Overview 2021 -Global Industry Report Share, Size, Comprehensive Growth, Development Trends, Key Manufactures and Regional Demand to Fore